URGN

UroGen Pharma Ltd.

Healthcare›Biotechnology|NASDAQ Global Market|US

Price

$18.82

Market Cap

$916.20M

Beta

1.37

P/E

0.0

Div Yield

—

Sector Median P/E

22.6

Key Metrics

Revenue Growth (YoY)+21.45%

EPS Growth (YoY)+0.93%

Revenue CAGR 3Y+19.49%

P/E Ratio0.0

PEG Ratio—

FCF Yield-17.76%

Debt / Equity0.00

Interest Coverage-3.7x

No credit card required

Already have an account? Sign in to view the full analysis for URGN.